MDGL vs. KBH
Compare and contrast key facts about Madrigal Pharmaceuticals, Inc. (MDGL) and KB Home (KBH).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MDGL or KBH.
Correlation
The correlation between MDGL and KBH is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MDGL vs. KBH - Performance Comparison
Key characteristics
MDGL:
0.71
KBH:
-0.61
MDGL:
1.37
KBH:
-0.68
MDGL:
1.16
KBH:
0.92
MDGL:
0.70
KBH:
-0.49
MDGL:
2.62
KBH:
-1.01
MDGL:
13.43%
KBH:
20.94%
MDGL:
59.83%
KBH:
36.51%
MDGL:
-98.40%
KBH:
-92.78%
MDGL:
-28.11%
KBH:
-39.10%
Fundamentals
MDGL:
$6.80B
KBH:
$3.87B
MDGL:
-$17.83
KBH:
$8.18
MDGL:
0.00
KBH:
0.63
MDGL:
40.39
KBH:
0.56
MDGL:
10.24
KBH:
0.94
MDGL:
$317.38M
KBH:
$6.85B
MDGL:
$306.81M
KBH:
$1.44B
MDGL:
-$376.15M
KBH:
$798.36M
Returns By Period
In the year-to-date period, MDGL achieves a -4.51% return, which is significantly higher than KBH's -17.20% return. Over the past 10 years, MDGL has underperformed KBH with an annualized return of 13.84%, while KBH has yielded a comparatively higher 15.53% annualized return.
MDGL
-4.51%
-6.15%
-15.99%
42.39%
26.60%
13.84%
KBH
-17.20%
0.32%
-33.59%
-22.08%
15.37%
15.53%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MDGL vs. KBH — Risk-Adjusted Performance Rank
MDGL
KBH
MDGL vs. KBH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Madrigal Pharmaceuticals, Inc. (MDGL) and KB Home (KBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MDGL vs. KBH - Dividend Comparison
MDGL has not paid dividends to shareholders, while KBH's dividend yield for the trailing twelve months is around 1.85%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDGL Madrigal Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
KBH KB Home | 1.85% | 1.45% | 1.12% | 1.88% | 1.34% | 1.25% | 0.67% | 0.52% | 0.31% | 0.63% | 0.81% | 0.60% |
Drawdowns
MDGL vs. KBH - Drawdown Comparison
The maximum MDGL drawdown since its inception was -98.40%, which is greater than KBH's maximum drawdown of -92.78%. Use the drawdown chart below to compare losses from any high point for MDGL and KBH. For additional features, visit the drawdowns tool.
Volatility
MDGL vs. KBH - Volatility Comparison
Madrigal Pharmaceuticals, Inc. (MDGL) has a higher volatility of 11.63% compared to KB Home (KBH) at 9.86%. This indicates that MDGL's price experiences larger fluctuations and is considered to be riskier than KBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MDGL vs. KBH - Financials Comparison
This section allows you to compare key financial metrics between Madrigal Pharmaceuticals, Inc. and KB Home. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MDGL vs. KBH - Profitability Comparison
MDGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Madrigal Pharmaceuticals, Inc. reported a gross profit of 132.74M and revenue of 137.25M. Therefore, the gross margin over that period was 96.7%.
KBH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, KB Home reported a gross profit of 282.82M and revenue of 1.39B. Therefore, the gross margin over that period was 20.3%.
MDGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Madrigal Pharmaceuticals, Inc. reported an operating income of -79.31M and revenue of 137.25M, resulting in an operating margin of -57.8%.
KBH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, KB Home reported an operating income of 127.34M and revenue of 1.39B, resulting in an operating margin of 9.2%.
MDGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Madrigal Pharmaceuticals, Inc. reported a net income of -73.24M and revenue of 137.25M, resulting in a net margin of -53.4%.
KBH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, KB Home reported a net income of 109.56M and revenue of 1.39B, resulting in a net margin of 7.9%.